Aridis Pharmaceuticals (ARDS) SEC Filings & 10K Form Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends Recent Aridis Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView06/28/20247:36 PMAridis Pharmaceuticals (Issuer)HAMILTON JOHN F (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/28/20247:36 PMAridis Pharmaceuticals (Issuer)Windham-Bannister Susan Richards (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/28/20246:46 PMAridis Pharmaceuticals (Issuer)Jafri Hasan (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/28/20246:32 PMAridis Pharmaceuticals (Issuer)Patzer Eric (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/28/20246:29 PMAridis Pharmaceuticals (Issuer)Truong Vu (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/27/20243:15 PMAridis Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20241:21 PMAridis Pharmaceuticals (Subject)ARMISTICE CAPITAL, LLC (Filed by)Form SC 13G/A02/13/20247:02 PMAridis Pharmaceuticals (Subject)Lind Global Fund II LP (Filed by)Form SC 13G/A01/16/20245:05 AMAridis Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/18/20238:40 AMAridis Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/18/20238:43 AMAridis Pharmaceuticals (Filer)Form DEFA14A11/06/20233:06 PMAridis Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/03/20234:00 PMAridis Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/03/20235:15 AMAridis Pharmaceuticals (Filer)Form DEFA14A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: Scopus BioPharma 10Q Form Ampio Pharmaceuticals 10Q Form Comera Life Sciences 10Q Form OncoSec Medical 10Q Form 180 Life Sciences 10Q Form Ainos 10Q Form Alvotech 10Q Form Alvotech 10Q Form Atlantic Coastal Acquisition Corp. II 10Q Form Atlantic Coastal Acquisition Corp. II 10Q Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ARDS) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aridis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aridis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARDS Stock Alerts